[Structural differences between various quality glutens and between their protein components].

A B Wakar; E G Pristschep; W W Kolpakowa

Home/Archive/PubMed

PubMed · 1226208

[Structural differences between various quality glutens and between their protein components].

A B Wakar·E G Pristschep·W W Kolpakowa

View original source ↗Export metadata ↓

Abstract

The rheological differences between glutens of varying quality are determined by the non-uniform "packing density" of the protein components in the gluten complex which is due to the different amounts of the structure-stabilizing disulphide and hydrogen linkages. There is no direct relationship between the gluten quality and the protein composition of the gliadine fraction. On the contrary, it is apparent that structural differences between the gluteline fractions from glutens of varying quality are essential. Some recent knowledge concerning such differences is discussed.

Explore related subjects

Amino Acids Deuterium Disulfides Gliadin Glutens Hydrogen Bonding Plant Proteins Protein Conformation Triticum Viscosity English Abstract Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

A B Wakar, E G Pristschep, W W Kolpakowa. 1975. [Structural differences between various quality glutens and between their protein components].. https://pubmed.ncbi.nlm.nih.gov/1226208/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2026

Chimeric structural isomer fragments as cost-efficient internal standards for amino acid quantification by mass spectrometry.

Amino acid (AA) profiles from body fluids such as blood and urine are clinical indicators for diagnosing metabolic and hepatic diseases. Current quantitative methods, such as liquid chromatography-mass spectrometry (LC-MS) with isotopically labelled internal standards (ISs), are costly and technically demanding. This study proposes a cost-efficient alternative using structural isomers as ISs in a direct liquid infusion (DLI) tandem mass spectrometry (MS/MS) approach. The method leverages chimeric spectra and fragment intensity ratios to quantify AAs, demonstrating high linearity and precision even with a 3D ion trap mass analyser. This approach offers a viable strategy for AA quantification in preventive medicine, particularly for screening metabolic diseases such as phenylketonuria, diabetes, and liver dysfunction.

Amino Acids↗

PubMed1992

A practical method for uniform isotopic labeling of recombinant proteins in mammalian cells.

A method to obtain uniformly isotopically labeled (15N and 15N/13C) protein from mammalian cells is described. The method involves preparation of isotopically labeled media consisting of amino acids isolated from bacterial and algal extracts supplemented with cysteine and enzymatically synthesized glutamine. The approach is demonstrated by producing 15N-labeled and 15N/13C-labeled urokinase from Sp2/0 cells and successfully growing Chinese hamster ovary (CHO) cells on the labeled media. Thus, using the procedures described, isotopically labeled proteins that have been expressed in mammalian cells can be prepared, allowing them to be studied by heteronuclear multidimensional NMR techniques.

Amino Acids↗

PubMed1992

A novel alpha-type fibrinogenase from Agkistrodon rhodostoma snake venom.

By means of CM-Sephadex C-50 column chromatography, gel-filtration on sephadex G-75 and Sephacryl S-200 columns, a purified fibrinogenase, kistomin, was obtained from venom of Agkistrodon rhodostoma. It was a single peptide-chain with a molecular mass of about 21,800 Da containing about 202 amino-acid residues as revealed by amino acid analysis. Kistomin preferentially cleaved A alpha- and subsequently the gamma-chain of fibrinogen, leaving the B beta-chain unaffected. Its fibrinogenolytic activity was estimated to be 36.6 +/- 4.5 mg/min per mg protein and was inhibited by the pretreatment of EDTA, suggesting that it is a metalloproteinase. Its fibrinogenolytic activity in platelet-poor plasma is much less potent as compared to that in purified fibrinogen solution. It inhibited ristocetin-induced aggregation of human platelets in a dose-dependent manner in the presence of von Willebrand factor.

Amino Acids↗